Investor News

Orbia Announces First Quarter 2026 Financial Results

Mexico City, April 28, 2026 – Orbia today released unaudited results for the first quarter of 2026. Orbia delivered revenues of $1.96 billion and EBITDA of $259 million for the quarter. Read more...

Orbia Announces CFO Transition and Appointment of Successor

Boston, February 25, 2026 – Orbia announced today that James P. “Jim” Kelly will retire as Chief Financial Officer after nearly five years of service. The Company also announced that Cristian “Cape” Capellino will assume the role of Chief Financial Officer effective March 15, 2026. Read more...

Orbia Announces Fourth Quarter and Full-Year 2025 Financial Results

Mexico City, Febrary 24, 2026 – Orbia today released unaudited results for the fourth quarter and full year of 2025. Orbia delivered reported EBITDA of $227 million for the fourth quarter of 2025 and $1,020 million for the full year 2025. Adjusted EBITDA was $236 million for the fourth quarter and $1,110 million for the full year. Read more...

MORE PRESS RELEASES

Zephex Scientist Preview.png

What’s Next for Zephex: Expert Q&A on Regulatory Milestones, Facility Expansion and Market Adoption

May 5, 2026 – As regulatory pressure accelerates and the phase down of high global warming potential inhaler medical propellants moves from policy to execution, pharmaceutical companies and investors are looking closely at which solutions are safe, sustainable and truly ready to scale. For Orbia Fluor & Energy Materials, Zephex® 152a represents a critical next step in the future of inhaled medicines — and 2026 marks an important year in that journey.

Following the recent approval of Orbia’s Drug Master File in the U.S. and the ramp up of its dedicated, commercial-scale manufacturing plant in the U.K., momentum around Zephex® 152a continues to build. In this Megatrendsetters Q&A, Sheryl Johnson, Application Development Manager for Orbia Fluor & Energy Material’s pharma business unit, and Chris Dodd, Global Regulatory Manager for Zephex® products, detail how the transition to Zephex® 152a is unfolding globally.

How Orbia Protects Business Continuity from Mine to Market

April 20, 2025 – This case study from FM, Orbia's property insurer, highlights Orbia's proactive approach to risk management. Hear from CFO Jim Kelly; Director of Risk Management & Insurance Brian Merkley and Senior Manager, Risk Management & Insurance Sofia Samperio on how Orbia protects business continuity and its people. Within the first two years of becoming an FM client, Orbia has closed more than 50 risk improvement recommendations. Read more...

Orbia Releases 2025 Impact Report; Demonstrating Sustainability-Enabled Resilience & Disciplined Value Creation

March 11, 2026 – Orbia released its 17th annual report, detailing its 2025 performance and strategic initiatives driving resilience and long-term value. Key performance highlights include: 90% of manufacturing sites achieving zero waste to landfill; 87% reduction in sulfur oxide emissions vs. 2018 baseline and continued progress toward 2030 emissions goals of 47% reduction in Scope 1 & 2 emissions and 30% reduction in Scope 3 emissions. Read more...

Orbia Honored as a Top Company in its Industry in the S&P Global Sustainability Yearbook for Fifth Consecutive Year

February 19, 2025 – Orbia has been named a member of the S&P Global Sustainability Yearbook for the fifth consecutive year. S&P Global Sustainability Yearbook members are the top performing companies within their industry. Orbia scored within the top 15% of companies in the chemicals category. In 2025, more than 9,200 companies were assessed with less than 10% selected for the 2026 Yearbook inclusion.Read more...